Literature DB >> 3891709

A comparison of the in-vitro activity of antimicrobials against Chlamydia trachomatis examined by Giemsa and a fluorescent antibody stain.

S J How, D Hobson, C A Hart, E Quayle.   

Abstract

Minimum concentrations for the inhibition of normal chlamydial inclusions (MICN) and abnormal inclusions (MICA) were obtained for a range of antimicrobials titrated against Chlamydia trachomatis in McCoy cell cultures. Each antibiotic titrated produced an MICN which was the same whether examined by Giemsa or fluorescent antibody staining methods (rifampicin 0.007 mg/l, tetracycline, erythromycin and penicillin 0.062 mg/l, chloramphenicol and spiramycin 0.25 mg/l, ciprofloxacin 1.0 mg/l, and cycloserine 250 mg/l). With the exception of penicillin the MICA (Giemsa) was between two- and four-fold higher than the MICN, and the MICA (fluorescent antibody) a further two-fold higher. Penicillin was alone in the wide concentration range over which abnormal inclusions were detected (0.0062 mg/l to 5 g/l).

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3891709     DOI: 10.1093/jac/15.4.399

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  13 in total

1.  In vitro activities of doxycycline and enrofloxacin against European Chlamydia psittaci strains from turkeys.

Authors:  P Butaye; R Ducatelle; P De Backer; H Vermeersch; J P Remon; F Haesebrouck
Journal:  Antimicrob Agents Chemother       Date:  1997-12       Impact factor: 5.191

Review 2.  Susceptibility testing of Chlamydia trachomatis: from eggs to monoclonal antibodies.

Authors:  J M Ehret; F N Judson
Journal:  Antimicrob Agents Chemother       Date:  1988-09       Impact factor: 5.191

3.  Commercially available fluorescein-conjugated monoclonal antibody for determining the in vitro activity of antimicrobial agents against Chlamydia trachomatis.

Authors:  J M Webberley; R S Matthews; J M Andrews; R Wise
Journal:  Eur J Clin Microbiol       Date:  1987-10       Impact factor: 3.267

4.  Evaluation of a seven day course of oxytetracycline in women with chlamydial cervicitis.

Authors:  D Hobson; O P Arya; P M Rao; N Lee; I A Tait; M G Bradley; H Mallinson
Journal:  Eur J Clin Microbiol       Date:  1986-10       Impact factor: 3.267

5.  Comparative in vitro activity of RU 28965 against Chlamydia trachomatis.

Authors:  R Cevenini; V Sambri; M La Placa
Journal:  Eur J Clin Microbiol       Date:  1986-10       Impact factor: 3.267

6.  Rapid determination of MICs of 15 antichlamydial agents by using an enzyme immunoassay (Chlamydiazyme).

Authors:  A Bianchi; C Scieux; C M Salmeron; I Casin; Y Perol
Journal:  Antimicrob Agents Chemother       Date:  1988-09       Impact factor: 5.191

7.  Antimicrobial susceptibility testing of Chlamydia trachomatis using a reverse transcriptase PCR-based method.

Authors:  N A Cross; D J Kellock; G R Kinghorn; M Taraktchoglou; E Bataki; K M Oxley; P M Hawkey; A Eley
Journal:  Antimicrob Agents Chemother       Date:  1999-09       Impact factor: 5.191

8.  Affinities of beta-lactams for penicillin binding proteins of Chlamydia trachomatis and their antichlamydial activities.

Authors:  C Storey; I Chopra
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

9.  In vitro susceptibilities of Ehrlichia risticii to eight antibiotics.

Authors:  Y Rikihisa; B M Jiang
Journal:  Antimicrob Agents Chemother       Date:  1988-07       Impact factor: 5.191

10.  In vitro activity of florphenicol.

Authors:  R Graham; D Palmer; B C Pratt; C A Hart
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-10       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.